The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast sums of money. But speakers at a MedCity INVEST panel warned that raising more capital than needed is not always… Read More »Investment in healthcare is soaring, but entrepreneurs must be wary of over-capitalizing
Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021? [Sponsored]
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as more SPACs search for targets, and company valuations grow, will the SPAC bubble burst?
The tilt was less pronounced in pharma and biotech, which attracted a record level of investment despite the Covid-19 pandemic according to a quarterly report on VC investment activity.